Data-driven to the drug of tomorrow

Opportunities and barriers of AI in a GxP world.

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.

Subscribe to the Merantix Momentum Newsletter now.

The latest industry news, interviews, technologies and resources.

How do you make 30 years of data accessible?

In conversation with Jonas Münch, who developed a RAG chatbot at Bayer that combines 30 years of internal data and clinical results in one place.

Addressing Challenges and Opportunities in Medical Writing Using AI

An interview with Dr. Richardus Vonk, Independent Advisor and Dr. Bertram Weiss, VP Health Vertical at Merantix Momentum.

Article

From bottleneck to breakthrough: Why AI is crucial for progress in healthcare and pharma

Rising costs, a shortage of specialists and a flood of data are pushing the healthcare system and the pharmaceutical industry to their limits. Why artificial intelligence is now the key to taking care, research and development to a new level.

Article

Clyravision: An entire forensics team in one system

Clyravision: The intelligent forensics system that not only recognizes manipulated images, but also explains exactly how and why they were altered - for more transparency and trust in the digital world.

Article

First to the Finish: How AI in Market Access Will Determine the Future Market Leaders in the Pharmaceutical Industry

Why the future of market access lies not in more processes, but in intelligent automation.

Data-driven to the drug of tomorrow

AI use cases in the pharmaceutical and healthcare industries.
The risks and potentials of AI in GxP as well as non-GxP processes.
Project report: supported document analysis for targeted identification of adverse drug reactions.